Yoshiko Fukuda
Chuo, 4093898, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Patient-Reported Visual Function and Vision-Related Quality of Life Across Ophthalmic Diseases: An Exploratory Cross-Sectional Study.
Journal: Journal of clinical medicine
Published: June 24, 2026
Ophthalmologists' Perceptions of the Impact of Patient Mental Status on Clinical Decision-Making: A Cross-Sectional Survey.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: April 28, 2026
Genetic factors associated with response to as-needed brolucizumab treatment for exudative age-related macular degeneration.
Journal: Japanese journal of ophthalmology
Published: January 16, 2026
Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 02, 2025
Genetic Factors Associated with Intraocular Inflammation After Brolucizumab Administration in Patients with Exudative Age-Related Macular Degeneration.
Journal: Genes
Published: June 08, 2025
Two year outcomes of as needed brolucizumab therapy in exudative age related macular degeneration with or without pachychoroid phenotype.
Journal: Scientific reports
Published: March 24, 2025
Short-Term Outcomes of Three Consecutive Monthly Loading Administrations of Aflibercept 8 Mg for Treatment-Naïve Exudative Age-Related Macular Degeneration.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 16, 2025
Clinical and genetic characteristics of simple central serous chorioretinopathy according to age.
Journal: Ophthalmic genetics
Published: November 11, 2024
Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 03, 2024
Last Updated: 09/26/2026